Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT Number: NCT00523601
To reassure the clinical study data on Seroquel antidepressant efficacy in patients who are diagnosed as bipolar depression
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Research Site, Kyungki-do, Goyang-si, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Or, any of the following is regarded as a criterion for exclusion from the programme:
AstraZeneca
Industry
A 8-Week, Multicenter, Open-Label, Observational Study of the Efficacy of Quetiapine Fumarate (SEROQUEL) Immediate-Release Tablets in Adult Patients With Bipolar Depression
Acronym: QUEEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03336918
Behavior, Behavioral Symptoms
Cleveland, Ohio, United States
View Trial DetailsNCT06516991
Bipolar Depression, Bipolar Disorder
Hangzhou, Zhejiang, China
View Trial DetailsNCT05228964
Anxiety Disorders, Behavior
Austin, Texas, United States
View Trial DetailsNCT04133233
Bipolar Depression, Bipolar Disorder
Créteil, Hôpital Albert Chenevier, France
View Trial Details